Lunch Wrap: ASX rises as MinRes slips
The ASX is on the rise on Friday, despite the Fed boss’s hawkish stance. Also, MinRes has admitted a slip-up and Cyclone Metals has surged after a deal with Vale.
News
All you need to know before the ASX opens
Good morning! Here’s everything you need to know before the ASX opens today.
Big miners suffer earnings hit as prices tank
Falling critical minerals prices have hit 50 of Australia’s largest miners, delivering a 37 per cent collective hit to their earnings in 2024.
Bitcoin, Palladium ETFs shine
The Aussie ETF industry has reached $233 billion with international stocks leading inflows, while Betashares launched an ethical Aussie bond ETF.
BYD to ‘see Ford in the rear-view mirror’
Chinese car maker BYD appears set to overtake US giant Ford in annual EV shipments. That’s largely because of demand for hybrids – which are also booming in Australia.
Asian demand fuels profits for Aussie LNG
WA-based gas stocks have every reason to cheer Asian demand growth – and a recent state government decision. Meanwhile, others are getting busy in SA and Queensland.
Drilling reawakens Spanish zinc stock
Variscan Mines has reawakened after returning with underground drilling at a zinc mine in Spain ignored for almost 100 years.
Archer Materials seems to be back on target
Collette Capital’s Steve Collette says interest is returning in semiconductor stock Archer Materials, which is eyeing new resistance levels after a mid-year slump.
Actinogen ‘on track’ with Alzheimer’s trial
ASX stock Actinogen reports its advanced – and novel – Alzheimer’s disease trial is recruiting strongly, with first results expected by mid next year.
Far East Gold’s initial inferred Idenburg estimate
Stockhead TV brings you today’s Break it Down, detailing the initial inferred resource estimate from Far East Gold’s Indonesian Idenburg project.
Life after Mt Isa for Queensland copper
Mt Isa’s underground copper mines are set to close in 2025, but Queensland explorers are looking to step into the breach.
Chinese show shot in the arm for health stocks
These ASX health stocks, which are cashing in on Chinese enthusiasm for Australian products, found a massive audience at the world’s largest trade show.
Guy on Rocks: Peregrine Gold
Guy Le Page goes into post-Trump metals markets before looking at Capricorn-adjacent Peregrine Gold as his stock of the week.
Imricor eyes cardiac ablation market prize
Barring unforeseen rivals, Imricor will have a 100 per cent share of the MRI-guided cardiac catheter ablation market, writes Tim Boreham.
Psychedelic vision has Emyria on a high
The Trump administration is expected to liberalise research into psychedelic-assisted therapies – and Emyria investors have taken note. Read more in our health wrap.
Gold bull run gets explorer drilling
BMG Resources and Metal Hawk are preparing to drill down on gold projects in WA’s northern Goldfields.
Explorers Podcast: WGR’s shovel-ready status
Western Gold Resources’ CEO Cullum Winn joins Barry FitzGerald on the Explorers Podcast to talk about the company’s Gold Duke project in the Goldfields region of Western Australia.
Closing Bell: ASX tumbles, banks, miners hit
The ASX dropped on Wednesday as banks and miners slid, with MinRes falling hard. And Trump has tapped Musk to lead a new DOGE department. Yep, you read that right.
Lunch Wrap: Banks fall as ‘Trump trades’ unwind
Bank stocks have fallen on the ASX on Wednesday, with gold dipping below $US2600. The news has been better for Nvidia, as it hit record highs.
Break it Down: BlinkLab
Host Fraser Palamara explains the major autism and ADHD study BlinkLab is getting involved in with Melbourne’s Monash University.
US drug launch no sweat for Botanix
A mix of good luck and good planning is set to pay off for Botanix – with its FDA-approved drug to treat excessive sweating in the process of a ‘soft’ US launch.
Plenty of broker love for gold-copper duo
These two ASX copper-gold stocks have attracted affection from brokers, with one given a price target more than double its current level.
Pieces falling into place for ASX health stocks
There is no shortage of ASX healthcare companies with upcoming catalysts – a focal point for investors. Here are five ready to make strong moves.
Iron ore price descent looms, warns expert
CBA’s mining guru says iron ore prices may sink below $US100/t, with China perhaps waiting for clear signals about US tariff intentions before boosting stimulus.
Miners slump, Bitcoin Trump bumps
ASX 200 drops as gold, iron ore, and energy stocks struggle. Paladin tumbles but Bitcoin… it’s had a bit of big day.
The ASX 200 wobbles again
The local bourse has fallen again as mining and energy stocks dip, with Paladin Energy cutting guidance and shares plunging over 20%.
Government bump for International Graphite
WA’s state government has signed a funding agreement that will usher in construction work on a new graphite plant in Collie.
Bitcoin tracks towards face-melting $100k
Bitcoin keeps hitting new highs, with investors eyeing $100K by December amid nation-state buying rumours and US reserve talks.
Meet the new global microcap flag bearers
LTR Pharma and EZZ Life Sciences have been promoted to a flagship global microcaps index, at the expense of Opthea. Read more in our health wrap.
Native Mineral Resources raises $3.5M
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the new share placement to advance gold projects from Native Mineral Resources.
Targeting concrete results with green cement
A (nearly) trillion-dollar market beckons for Suvo as it revolutionises cement production – which ‘accounts for more emissions than the entire global car fleet’.
Recce’s Indonesian approval
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the new diabetic foot infection treatment trial from Recce Pharmaceuticals.
Portfolio protection in the Age of Trump 2.0
Donald Trump’s election adds further risks to elevated share valuations and investors might want to think of protection.
Raging gold has juniors racing
Gold is crashing through record highs, and that has juniors itching to get into production and capitalise when the price is right.
Closing Bell: ASX miners pull back, Bitcoin soars
ASX mining stocks have fallen on Monday, as Resolute Mining dropped following its CEO’s Mali detention, and Bitcoin rocketed to an all-time high, past $US81k.
ASX Small Caps Lunch Wrap
Local markets lifted by news about US rate cuts, uranium stocks soared on supply cut.
ASX Lunch Wrap: Things look grim for Resolute
Mining and China-sensitive stocks have dipped on Monday, with Resolute Mining plunging after its CEO’s detention in Mali.
ASX Top 10 at 11… ish
A fintech junior and a copper hunter are standouts in Monday morning trade, while more broadly, miners have slumped.
Tony’s Takeaway: Talisman Mining
Tony looks at Talisman Mining, who has Kerry Harmanis on board and is using its MinRes royalties to fund some exciting exploration plays.
12 stocks set to gain from Trump shake-ups
US President-elect Trump’s promised tariffs could drive up prices and inflation – bad news for Australia – but these ASX stocks may benefit from his policies.
Another Tasmanian dasher set to star
Gold prices are at super levels, and veteran resources scribe Barry FitzGerald is intrigued by Tasmanian explorer Flynn Gold.
A copper-goldie flying under the radar
While Cannindah’s share price has more than halved this year, the Queensland junior has quietly been ticking off milestones, says Kristie Batten.
ASX developers with an appetite for copper
Copper prices have tumbled but supply remains tight in a world increasingly hungry for the red metal. These ASX developers are working hard to address the shortfall.
ASX-bound explorer eyes rich neighbourhood
A new explorer plans to list on the bourse, then make itself at home in NSW’s prolific Lachlan Fold Belt, with some of Australia’s top gold mines for neighbours.
Investors adore Equinox’s 70pc antimony
Equinox soars on record 70% antimony grades at Alturas, NMR buys two QLD gold assets for $18.9m and Pantera well tests Smackover.
Lithium leaders ride out the storm
Albemarle cuts back and Arcadium reports skinny earnings as lithium producers keep trying to ride out the storm of low prices.
Initiatives natural fit for ethical investors
It’s good news all round for investors wanting to promote biodiversity, with a new index, a strategy for nature and the exciting ‘Nature Positive Matters’ initiative.
Closing Bell: ASX pops on tech, banks, gold
The ASX rallied in Friday action on tech gains, with CBA hitting a record and Neuren soaring. Meanwhile, Asian markets rose on China stimulus hopes.
Lunch Wrap: ASX jumps on gold rally
The ASX rose on Friday morning, thanks to Wall Street’s gains and China stimulus hopes. The bourse was led by gold miners, while Block dropped despite profit growth.
Vulcan Energy Resources produces first lithium hydroxide
Stockhead TV brings you today’s Break it Down, detailing the first European production of lithium hydroxide by Vulcan Energy Resources.
WA government digs deep for explorers
The new round of WA’s Exploration Incentive Scheme scheme will boost the quest for critical minerals and gold, as 50 successful applicants share $7.28m in grants.
Native Mineral Resources goes for gold
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the new gold project acquisitions from Native Mineral Resources.
What does Trump 2.0 mean for IRA?
Donald Trump is likely to repeal elements of Biden’s Inflation Reduction Act to focus on fossil fuels over electric vehicles.
Tony’s Takeaway: Triangle Energy
Tony looks at a cashed up Triangle Energy now ready to push some chips into a big-time Perth Basin oil play.
The explorers Trump bump didn’t dump
Strickland is up around 4 per cent, King River has risen on Kurundi gold and Australian Critical Minerals is eyeing Pilbara iron ore. Get your resources wrap here.
Closing Bell: ASX swings wildly, Energy rises
The ASX was up and down on Thursday, with Quickstep and Sigma Healthcare in the spotlight. All after Wall Street hit record highs following Trump’s win.
Neuren’s Willy Wonka ticket is worth $US50m
Drug developer Neuren Pharmaceuticals has pocketed a $US50 million windfall from a so-called FDA ‘priority review voucher’. Read that and more in our health wrap.
Lunch Wrap: ASX down, Quickstep up
The ASX has slipped overall on Thursday morning but energy stocks, Tesla, and Bitcoin have surged on Trump’s win. Sigma Healthcare and Quickstep have been soaring today, too.
EMC’s critical appointment
Stockhead TV brings you today’s Break it Down, detailing a new appointment set to advance Everest Metals’ Mt Edon critical minerals operation.
West Africa: The golden child for discoveries
West Africa is emerging as a global hotspot for gold M&A as record prices and rich geology entice miners. These ASX players are in the thick of the action.
Stocks, USD, Bitcoin soar
Stocks surge, US dollar rises, and Bitcoin hits record as Trump leads in tight US election.
ASX ressies lead with copper and gold
Lord bets on copper, Saudi gold lights up investor eyes to AuKing and rock chip grades up to 24.2g/t gold erupt Red Mountain shares.
Guy on Rocks: North of the border with White Cliff Minerals
With election fever heating up in the US, host Guy Le Page takes us north of the border to Nunavut and the Northwest Territories in Canada.
Indonesian gold on the mind of nickel legend
Nickel Industries boss Justin Werner has returned to his roots, stepping up to become chairman at the Indonesian gold company he founded Far East Gold.
AuKing going for gold in Saudi
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the new Saudi gold exploration licence awarded to AuKing Mining.
Lunch Wrap: ASX golden on US election day
The ASX has risen on Wednesday morning, with tech and mining stocks rallying. Meanwhile Nvidia has over taken Apple and the US election results are trickling in.
Support for ‘brain iron overload’ treatment
A prestigious scientific publication has endorsed the mechanism of action of Alterity Therapeutics’ neurological drug candidate. Read more in our health wrap.
Top 10 at 11: fresh from the ASX today
Australian equities have climbed higher at the open, tracking a strong rally on Wall Street overnight as first results of the US presidential election start to flow through.
Self-sufficiency the Alkane way
Alkane boss Nic Earner lays down the case for self-sufficient exploration to production with insights into his company’s journey.
Imaging stocks eye US veterans health market
With their innovative tech, ASX medical imaging companies are capitalising on the lucrative opportunity of caring for US veterans.
Uscom, Respiri lead slow sector
Uscom and Respiri lead a sluggish ASX healthcare sector, as Saxo Markets’ Jessica Amir cautions that ‘time in the market, not timing, is key’.
Two-pronged plan to put ‘mozz’ on dengue fever
With dengue fever spreading to colder climates, Island Pharmaceuticals is working on a preventative and therapeutic solution to a complex problem.
Iron ore death rumours greatly exaggerated
Former Rio and Arcelor Mittal man Paul Berend – now heading Cyclone Metals – says the iron ore outlook for new developers is brighter than many think. Here’s why.
ASX explorers rise on project milestones
BMG says it’s fully-funded to expand the 518,000oz gold resource at Abercromby and both Bubalus and Talga rise on environmental wins.
Break it Down: St Barbara’s raise
In this episode, host Fraser Palamara details how gold miner St Barbara plans to spend the $110 million it’s raising for the Simberi project.
Cancer fighter looks beyond ‘low-hanging fruit’
Chimeric Therapeutics has struck major blows against blood cancer, but as it plans a homecoming it is taking aim at tougher targets, with its next-gen Car-T drugs.
Closing Bell: ASX slips as RBA holds rates
Aussie shares have dipped on Tuesday as RBA holds rates, MinRes rebounds, and Kamala Harris leads in Iowa.
Biotech firms face ‘second strike’ risk
Several biotech companies are at risk of a remuneration report ‘second strike’ and subsequent board spill motion.
Stocks down, all eyes on RBA and Vauban.
The ASX starts sluggish with eyes on the RBA and Melbourne Cup; Domino’s drops as Mineral Resources rises.
Break it Down: Veni, vidi, vici
Augustus Minerals has acquired a new gold project north of Leonora in Western Australia amongst some big hitters.
Original URL: https://www.news.com.au/finance/business/stockhead/news/page/24